Key facts
- Ambient Clinical Analytics’s last known valuation is $7.4M (Jan 2022).
- It has raised $15.6M across 8 recorded rounds; the latest was Seed Round ($1.6M) in Mar 2024.
- Notable investors include Social Capital, Mayo Clinic Ventures, Lateral Capital Management, Noaber Ventures, Bluestem Capital Company — 13 tracked in total.
- Ambient Clinical Analytics has filed 11 Form Ds with the SEC since 2014, most recently Apr 2024 ($1.6M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Ambient Clinical Analytics
Funding rounds
8 roundsAbout Ambient Clinical Analytics
Developer of healthcare tools designed to reduce healthcare costs and improve patient outcomes. The company's tools provide digital health and clinical decision support automation tools designed for bedside, nurse station, clinical command center, and remote monitoring, enabling physicians and medical personnel to spend more time with patients instead of reviewing information.
- Sector
- Healthcare
- HQ
- Rochester, MN, United States
- Founded
- 2014
- Employees
- 13
- Website
- ambientclinical.com/
- Ownership
- Privately Held (backing)
Ambient Clinical Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ambient Clinical Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ambient Clinical Analytics in its N-PORT filings yet. We sweep new filings monthly.